Trial of Gemcitabine and Cisplatin in Patients With Inoperable Biliary Tract Carcinomas

Clinical trial NCT00490399 · COMPLETED

Trial details

NCT number: NCT00490399
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Biliary Tract Carcinoma

Start date: 2003-03-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.